BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17579610)

  • 1. Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.
    Buxbaum JD; Georgieva L; Young JJ; Plescia C; Kajiwara Y; Jiang Y; Moskvina V; Norton N; Peirce T; Williams H; Craddock NJ; Carroll L; Corfas G; Davis KL; Owen MJ; Harroch S; Sakurai T; O'Donovan MC
    Mol Psychiatry; 2008 Feb; 13(2):162-72. PubMed ID: 17579610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes.
    Takahashi N; Sakurai T; Bozdagi-Gunal O; Dorr NP; Moy J; Krug L; Gama-Sosa M; Elder GA; Koch RJ; Walker RH; Hof PR; Davis KL; Buxbaum JD
    Transl Psychiatry; 2011 May; 1(5):e8. PubMed ID: 22832403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.
    Norton N; Moskvina V; Morris DW; Bray NJ; Zammit S; Williams NM; Williams HJ; Preece AC; Dwyer S; Wilkinson JC; Spurlock G; Kirov G; Buckland P; Waddington JL; Gill M; Corvin AP; Owen MJ; O'Donovan MC
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jan; 141B(1):96-101. PubMed ID: 16249994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.
    Bjarnadottir M; Misner DL; Haverfield-Gross S; Bruun S; Helgason VG; Stefansson H; Sigmundsson A; Firth DR; Nielsen B; Stefansdottir R; Novak TJ; Stefansson K; Gurney ME; Andresson T
    J Neurosci; 2007 Apr; 27(17):4519-29. PubMed ID: 17460065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.
    Law AJ; Wang Y; Sei Y; O'Donnell P; Piantadosi P; Papaleo F; Straub RE; Huang W; Thomas CJ; Vakkalanka R; Besterman AD; Lipska BK; Hyde TM; Harrison PJ; Kleinman JE; Weinberger DR
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12165-70. PubMed ID: 22689948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population.
    Shiota S; Tochigi M; Shimada H; Ohashi J; Kasai K; Kato N; Tokunaga K; Sasaki T
    J Hum Genet; 2008; 53(10):929-935. PubMed ID: 18704261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.
    Nicodemus KK; Law AJ; Radulescu E; Luna A; Kolachana B; Vakkalanka R; Rujescu D; Giegling I; Straub RE; McGee K; Gold B; Dean M; Muglia P; Callicott JH; Tan HY; Weinberger DR
    Arch Gen Psychiatry; 2010 Oct; 67(10):991-1001. PubMed ID: 20921115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.
    Deng C; Pan B; Engel M; Huang XF
    Psychopharmacology (Berl); 2013 Mar; 226(2):201-15. PubMed ID: 23389757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.
    Banerjee A; Macdonald ML; Borgmann-Winter KE; Hahn CG
    Brain Res Bull; 2010 Sep; 83(3-4):132-9. PubMed ID: 20433909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia.
    Georgieva L; Moskvina V; Peirce T; Norton N; Bray NJ; Jones L; Holmans P; Macgregor S; Zammit S; Wilkinson J; Williams H; Nikolov I; Williams N; Ivanov D; Davis KL; Haroutunian V; Buxbaum JD; Craddock N; Kirov G; Owen MJ; O'Donovan MC
    Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12469-74. PubMed ID: 16891421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia.
    Law AJ; Kleinman JE; Weinberger DR; Weickert CS
    Hum Mol Genet; 2007 Jan; 16(2):129-41. PubMed ID: 17164265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.
    Mei L; Xiong WC
    Nat Rev Neurosci; 2008 Jun; 9(6):437-52. PubMed ID: 18478032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between the protein tyrosine phosphatase, receptor-type, Z Polypeptide 1 (PTPRZ1) gene and schizophrenia in the Japanese population.
    Ito Y; Yamada S; Takahashi N; Saito S; Yoshimi A; Inada T; Noda Y; Ozaki N
    Am J Med Genet B Neuropsychiatr Genet; 2008 Oct; 147B(7):1013-8. PubMed ID: 18186075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.
    Hahn CG; Wang HY; Cho DS; Talbot K; Gur RE; Berrettini WH; Bakshi K; Kamins J; Borgmann-Winter KE; Siegel SJ; Gallop RJ; Arnold SE
    Nat Med; 2006 Jul; 12(7):824-8. PubMed ID: 16767099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients.
    Chong VZ; Thompson M; Beltaifa S; Webster MJ; Law AJ; Weickert CS
    Schizophr Res; 2008 Mar; 100(1-3):270-80. PubMed ID: 18243664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells.
    Fiddes RJ; Janes PW; Sanderson GM; Sivertsen SP; Sutherland RL; Daly RJ
    Cell Growth Differ; 1995 Dec; 6(12):1567-77. PubMed ID: 9019162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.
    Pitcher GM; Kalia LV; Ng D; Goodfellow NM; Yee KT; Lambe EK; Salter MW
    Nat Med; 2011 Apr; 17(4):470-8. PubMed ID: 21441918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase beta/zeta-signaling pathway: regulation of tyrosine phosphorylation of Fyn by pleiotrophin.
    Pariser H; Ezquerra L; Herradon G; Perez-Pinera P; Deuel TF
    Biochem Biophys Res Commun; 2005 Jul; 332(3):664-9. PubMed ID: 15925565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of ErbB4 with schizophrenia: association and expression studies.
    Silberberg G; Darvasi A; Pinkas-Kramarski R; Navon R
    Am J Med Genet B Neuropsychiatr Genet; 2006 Mar; 141B(2):142-8. PubMed ID: 16402353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.